EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

The impact of non-acute decompensation of cirrhosis on patient mortality

João Carlos Gonçalves, Ana Raquel Cruz, Sofia Xavier, Joana Magalhães, Carla Marinho, José Cotter

Digestive and Liver Disease · 2026

DOI: 10.1016/j.dld.2026.01.227 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Digestive and Liver Disease, 2026. Verfasst von João Carlos Gonçalves und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Unidade Local de Saúde do Alto Ave, Guimarães, Portugal; Life and Health Sciences Research Institute (ICVS), School of M…. Hauptthemen laut MEDLINE: Liver Cirrhosis. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Cirrhosis progression from compensated to decompensated stage signals a deterioration in prognosis, with episodes of acute decompensation (AD) carrying a high risk of short-term mortality. Recently, the concept of non-acute decompensation (NAD) has emerged, representing a more insidious form of decompensation that is nonetheless associated with increased mortality. We aimed to evaluate the clinical impact of NAD in a hospital-referred hepatology population. METHODS: Single-center, retrospective, longitudinal observational study which included adult patients with compensated cirrhosis followed between 2013-2025. RESULTS: Data from 391 patients were analyzed, 72.1% male with a mean age of 59.9±11 years. Of those, 215 did not decompensate (ND), 121 developed NAD and 55 developed AD. The baseline independent predictors of NAD included a higher MELD score, lower serum albumin and non-compliance with the effective etiological treatment. AD was predicted by lower serum albumin, lower platelet count and non-compliance with the effective etiological treatment. Mortality was significantly higher in NAD (HR 10.82; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisHumansMaleMiddle AgedRetrospective StudiesDisease ProgressionFemalePrognosisLongitudinal StudiesAgedSeverity of Illness IndexSerum AlbuminPlatelet CountRisk Factors

Stichwörter der Autor:innen

Acute decompensationCirrhosisLiver transplantationMortalityNon-acute decompensation

Substanzen

Serum Albumin

Autor:innen und Institutionen

  • Gastroenterology Department, Unidade Local de Saúde do Alto Ave, Guimarães, Portugal; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Governme…
  • Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal. Electronic address: anamoreiracruz…

Zitieren

APA

Gonçalves, J. C., Cruz, A. R., Xavier, S., Magalhães, J., Marinho, C., & Cotter, J. (2026). The impact of non-acute decompensation of cirrhosis on patient mortality. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.01.227

Vancouver

Gonçalves JC, Cruz AR, Xavier S, Magalhães J, Marinho C, Cotter J. The impact of non-acute decompensation of cirrhosis on patient mortality. Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2026.01.227

BibTeX
@article{Gonalves2026,
  author = {Gonçalves, João Carlos and Cruz, Ana Raquel and Xavier, Sofia and Magalhães, Joana and Marinho, Carla and Cotter, José},
  title = {The impact of non-acute decompensation of cirrhosis on patient mortality},
  journal = {Digestive and Liver Disease},
  year = {2026},
  doi = {10.1016/j.dld.2026.01.227}
}
Kostenlos starten →